Targeting pancreatic cancer with magneto-fluorescent theranostic gold nanoshells
We report a magneto-fluorescent theranostic nanocomplex targeted to neutrophil gelatinase-associated lipocalin (NGAL) for imaging and therapy of pancreatic cancer. Gold nanoshells resonant at 810 nm were encapsulated in silica epilayers doped with iron oxide and the near-infrared (NIR) dye indocyani...
Saved in:
Published in | Nanomedicine (London, England) Vol. 9; no. 8; pp. 1209 - 1222 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
Future Medicine Ltd
01.06.2014
Future Medicine |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | We report a magneto-fluorescent theranostic nanocomplex targeted to neutrophil gelatinase-associated lipocalin (NGAL) for imaging and therapy of pancreatic cancer.
Gold nanoshells resonant at 810 nm were encapsulated in silica epilayers doped with iron oxide and the near-infrared (NIR) dye indocyanine green, resulting in theranostic gold nanoshells (TGNS), which were subsequently conjugated with antibodies targeting NGAL in AsPC-1-derived xenografts in nude mice.
Anti-NGAL-conjugated TGNS specifically targeted pancreatic cancer cells
and
providing contrast for both NIR fluorescence and T
-weighted MRI with higher tumor contrast than can be obtained using long-circulating, but nontargeted, PEGylated nanoparticles. The nanocomplexes also enabled highly specific cancer cell death via NIR photothermal therapy
.
TGNS with embedded NIR and magnetic resonance contrasts can be specifically targeted to pancreatic cancer cells with expression of early disease marker NGAL, and enable molecularly targeted imaging and photothermal therapy.
Original submitted 6 November 2012; Revised submitted 25 March 2013 |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 Equal contributing first authors |
ISSN: | 1743-5889 1748-6963 |
DOI: | 10.2217/nnm.13.84 |